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Abstract
Surgical treatment for early-stage breast carcinoma primarily necessitates breast conserv-
ing therapy (BCT), where the tumour is removed while preserving the breast shape. To
date, there have been very few attempts to develop accurate and efficient computational
tools that could be used in the clinical environment for pre-operative planning and oncoplas-
tic breast surgery assessment. Moreover, from the breast cancer research perspective,
there has been very little effort to model complex mechano-biological processes involved in
wound healing. We address this by providing an integrated numerical framework that can
simulate the therapeutic effects of BCT over the extended period of treatment and recovery.
A validated, three-dimensional, multiscale finite element procedure that simulates breast tis-
sue deformations and physiological wound healing is presented. In the proposed methodol-
ogy, a partitioned, continuum-based mathematical model for tissue recovery and
angiogenesis, and breast tissue deformation is considered. The effectiveness and accuracy
of the proposed numerical scheme is illustrated through patient-specific representative
examples. Wound repair and contraction numerical analyses of real MRI-derived breast
geometries are investigated, and the final predictions of the breast shape are validated
against post-operative follow-up optical surface scans from four patients. Mean (standard
deviation) breast surface distance errors in millimetres of 3.1 (±3.1), 3.2 (±2.4), 2.8 (±2.7)
and 4.1 (±3.3) were obtained, demonstrating the ability of the surgical simulation tool to pre-
dict, pre-operatively, the outcome of BCT to clinically useful accuracy.
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Introduction
Breast cancer is currently the most common cancer in Europe, with 464,000 cases recorded in
2012 [1]. It is also the most prevalent cancer (20%), surpassing both prostate (18%) and large
bowel (13%) cancers. However, five year survival of breast cancer currently exceeds 80% in
both Europe and the USA [2–4], with the result that more and more women are living with the
consequences of their treatment. This treatment is primarily surgical, but may also involve
adjuvant therapies, such as chemotherapy and radiotherapy. Whilst around 1% of breast cancer
cases do occur in men, mastectomy is usually the recommended treatment. As this study is
solely concerned with breast conserving therapy, male breast cancer is not considered further.
Evaluation of the aesthetic outcome of breast conserving therapy suggests that 6% of patients
receive a poor cosmetic result and up to 30% of patients may be dissatisfied with their appear-
ance after treatment [5]. This has prompted interest in developing objective, standardised tools
for the evaluation of the cosmetic outcome [6]. This outcome is a function of many factors,
however, including tumour size and location, the volume of the breast, its density, and the dose
and distribution of radiotherapy [5]. There is a clear requirement therefore, for tools that could
predict the cosmetic outcome of breast surgery and support the collaborative decision making
process between surgeon and patient in choosing from the range of surgical and therapeutic
options available. These include identifying when simple breast conserving surgery may be via-
ble, given shrinkage of the tumour following neo-adjuvant chemotherapy for instance, or
whether more complex oncoplastic breast conserving surgery or mastectomy, with or without
reconstruction, will be required in order to obtain the desired aesthetic outcome.
Wound healing is a complex biological process involving the coordinated actions of multi-
ple cell types, a variety of important proteins and chemicals responsible for cell signalling, and
micro-environmental conditions [7]. It is essential that surgeons understand the key physiolog-
ical processes involved, such that the most important factors influencing successful wound
healing can be identified and optimised. This could improve the outcome of breast conserving
therapy (BCT) interventions and reduce negative effects from adverse wound healing.
An overview of the biological and molecular mechanisms that regulate wound healing and
angiogenesis is provided in S1 File. A detailed understanding of these processes may enable
new surgical techniques to be developed, enhance our ability to treat chronic wounds and
improve our ability to deliver an optimal treatment for cancer. Mathematical modelling and
computer simulations can further this aim by improving our understanding of the processes
involved in tissue regeneration and vascular sprouting. The state-of-the-art in this field is out-
lined in the next two subsections.
Mathematical Modelling of Tissue and Vascular Network Regeneration
Wound healing and angiogenesis are very challenging and complex mechano-biological pro-
cesses to investigate and hence difficult to model mathematically. With the advent of bioengi-
neering and high-performance computing, significant effort towards realistic and more
accurate simulations of such biological processes has been carried out within the last two
decades. In the literature various mathematical models that investigate certain aspects of soft
tissue regeneration and vascular sprouting have been described. In this respect, the two-volume
manuscript of Murray [8, 9] is an excellent resource in biology mathematical modelling,
including tissue growth, dermal and epidermal wound healing, cancer development, etc.
Most of the existing mathematical formulations in the field are founded on the established
Oster-Murray-Harris model [10] for morphogenesis. However, amongst the first to simulate
epidermal wound recovery was Sherratt and Murray [11], who proposed a very simple mathe-
matical model for the healing of circular epidermal wounds. Also, Tranquillo and Murray [12]
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employed a continuum model that couples the conservation laws for fibroblast cells and the
extracellular matrix (ECM) density, with the balance equation for the epidermis. Olsen and col-
leagues [13] developed a more complex mechano-chemical model for adult mammalian skin
wound contraction that also considers the dynamic consumption and production of the chemi-
cal stimulus in cell function and phenotypic transformation between fibroblasts and myofibro-
blasts. Ramtani et al. [14] presented a fibroblast-collagen-matrix contraction model to
numerically study the biomechanical interactions that regulate wound contraction of connec-
tive tissue cells and investigated the effect of ECM remodelling in conjunction with ECM den-
sity, cell number and cell-matrix interaction stress.
Manoussaki was amongst the first to propose a coupled mechano-chemical model of angio-
genesis and vasculogenesis using a finite difference scheme to simulate in-vitro vascular net-
work formation [15]. A more detailed continuum-based model of angiogenesis was later
proposed by Schugart et al. that consisted of a system of seven non-linear partial differential
equations accounting the key components of wound healing [16]: capillary tips and sprouts,
fibroblasts, inflammatory cells, a chemo-attractant, oxygen level and the ECM. Javierre et al.
[17] extended the mathematical model of [13] by considering cell mechanical sensing and
transmission of traction forces to the ECM, mechano-sensitive cell differentiation, and a
dynamic change of the ECMmechanical properties with collagen deposition. Also, Xue and
colleagues [18] presented a two-dimensional, mathematical model of ischemic dermal wound
healing, where a set of coupled PDEs—involving the concentration of oxygen, vasculogenesis
chemical agents, the density of macrophages, fibroblasts, capillaries and the density and veloc-
ity of the ECM—were solved monolithically. Flegg et al. [19] proposed a three-species (oxygen
level, capillary tip and blood vessel density) mathematical model of wound healing to simulate
the application of hyperbaric oxygen therapy in the treatment of chronic wounds. The model
was later improved into a six-species one and was used to assess chronic diabetic wound treat-
ment strategies with hyperbaric oxygen [20]. Valero et al. [21] presented a two-dimensional FE
model for the simulation of skin wound recovery and scarring, where a mechano-sensitive bio-
chemical model in angiogenesis is employed.
Breast Tissue Biomechanical Modelling
Development of a high-fidelity patient-specific surgical simulator—namely a computational
model of oncoplastic breast surgery (OBS) interventions—which could potentially be used in
the clinical environment is a challenging task. Accurate and reliable biomechanical modelling
requires knowledge of the anatomy and an understanding of the biology of the system under
consideration. The female breast is composed of adipose tissue, glandular lobules and milk
ducts, connective tissues and the dermis (see Chapter 2A in [22]). The glandular lobules and
milk ducts are concerned with milk production and are surrounded by dense connective tis-
sues, which are collectively referred to as fibroglandular tissue. The breast is attached posteri-
orly to the chest by the pectoralis fascia over the pectoral muscle, while its shape is established
and maintained by the skin and the supporting Cooper’s ligaments.
In the past few years, novel computer algorithms have been developed in the field of breast
cancer research, for surgical training and pre-operative planning, image guided surgery, diag-
nosis and clinical biopsy. Much of this work has focussed mainly on modelling the breast
deformations associated with radiological acquisitions, such as mammographic plate compres-
sions [23–27] for the purposes of image registration.
However, a small number of studies have been undertaken with a specifically surgical plan-
ning or outcome prediction focus. Roose et al. [28] developed a computer-based planning tool
to predict the surgical outcome of breast augmentation procedures by sub-glandular placement
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of an implant above the pectoralis major. In related work, Lapuebla-Ferri et al. [29] presented
an FE procedure of breast augmentation through silicone implant insertion. Del Palomar et al.
[30] proposed a numerical procedure, based on the FE method, to simulate breast deforma-
tions after lumpectomy. Garbey et al. [31] presented a two-dimensional modelling approach to
predict the surgery outcome after breast tumour resection, using a coupled FE biomechanical
model and a cellular automata wound healing model. Patete et al. [32] developed and validated
a three-dimensional female breast deformation model for computer assisted breast surgery and
breast biopsy analysis, whose modelling approach was based on the mass-spring method.
This contribution presents the work of two EU-funded projects (see the Acknowledgments
section) that aim to develop novel in-silico modelling tools of breast mechano-biology, and
innovative techniques towards surgical planning and outcome prediction of BCT using a com-
bination of various imaging modalities, i.e. magnetic resonance imaging (MRI), optical surface
scans (3dMD), etc. In this paper we present a novel technique to biomechanically model the
anatomy of the breast on a patient-specific basis. We propose an integrated predictive tool that
accounts for the effect of surgical removal of early-stage breast carcinoma via lumpectomy; it
predicts the post-operative results of wound healing, while it can potentially accommodate the
side-effects of adjuvant chemo- and radiotherapy. Ultimately, the tool developed can be used
to explore surgical strategies and the consequences of the available options with respect to the
final appearance of the patient’s breast.
In this paper we deliver a three-dimensional surgical simulator for computer-aided surgical
planning in BCT of early stage breast cancer patients. To date, there are no standard tools for
aesthetic assessment and prediction of lumpectomy intervention outcomes, and no related
tools to support patient-surgeon interaction or multi-disciplinary team meetings to aid a
shared decision making process. To the best of our knowledge, this is the first attempt to model
—in an integrative manner—breast tissue biomechanics and physiological soft-tissue recovery.
More importantly, this work pioneers in presenting a validated modelling framework by using
a combination of different imaging modalities (MRI and 3dMD surface acquisitions) before
and 6 to 12 months after OBS.
Materials and Methods
Ethics
Patients gave written informed consent in line with Good Clinical Practice and the Declaration
of Helsinki. The trial was approved by the London—Camden & Islington National Research
Ethics Committee (reference 14/LO/1117) in accordance with the PICTURE Breast L (https://
clinicaltrials.gov/ct2/show/NCT02341820) study protocol.
In this section, the finite element (FE) modelling procedure for oncoplastic breast surgery
techniques, along with patient-specific biomechanical modelling is presented. The structure of
this section is as follows: First, a description of the mathematical modelling of the wound heal-
ing and angiogenesis analysis is given, followed by an outline of the relevant biomechanical
model of breast tissue. Subsequently, the coupled multiscale FE procedure for the developed
mechano-biological modelling framework is described. This section concludes with the presen-
tation of the onco-plastic surgical simulation tool.
Wound Healing and Angiogenesis FE Model
The basic mathematical model for tissue recovery by Sherratt and Murray is followed here
[11]. We adopt a five-species physiological wound healing and angiogenesis model that con-
tains the following state variables: the cell density, η, the concentration of a biochemical agent
that regulates mitosis, B, the microvascular network density, υ, the oxygen and nutrient level, ξ,
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and an agent to regulate vascular sprouting, i.e. the macrophage-derived growth factor
(MDGF), μ.
The cell density (e.g. fibroblasts, myofibroblasts, smooth muscle cells, etc.) balance is
described by a reaction-diffusion partial differential equation (PDE), which in the general form
is also referred to as the Kolmogorov-Petrovsky-Piskounov equation, i.e.
_Z ¼ DZr2Zþ kB SðBÞ ð2 Z0 Z Z2Þ  k Z ; ð1Þ
where Dη is an isotropic diffusion coefﬁcient (in m
2/s), η0 is the reference cell density in the
undamaged tissue region, and kB is a linear rate (given in m
3cell-1s-1) that describes the produc-
tion of cells in the wound, while k is the natural cell loss or death rate (in s-1). Following [11],
function S reﬂects the chemical control of cell mitosis either as an activator or as an inhibitor,
hence, taking the form respectively
SðBÞ ¼ 2 h1 B B
B2 þ B2 þ h2 ; and SðBÞ ¼
ðh0  1Þ Bþ h0 B0
2ðh0  1Þ Bþ B0
;
where h0,1,2 and B are parameters modulating the production rate of cells (see S1 Table).
In wound healing, chemical growth factors fulfil the task of triggering or suspending the
production of soft tissue cells, i.e. breast tissue cells in this work. To date, various factors which
chemically regulate cell mitosis and thus tissue recovery have been reported, two of which are
the keratinocyte growth factor and the basic fibroblast growth factor. However, in the present
mathematical model, a homogenised species B is assumed to model biochemical regulation of
cell division. Here chemical growth transport is described by the parabolic equation
_B ¼ DBr2Bþ ‘Z Z ‘ B ; ð2Þ
where DB is the corresponding chemical diffusion coefﬁcient (in m
2/s), while the second and
third term on the right-hand side of Eq (2) describe the production of the chemical by the cells
and the decay of B respectively (see S1 Table).
Capillary-tip sprouting and endothelial wall formation can be mathematically modelled by
a simplified version of Fisher’s equation where the diffusive term is omitted [33]:
_u ¼ bHðmÞ ðu0 u u2Þ ; ð3Þ
where υ0 is the reference microvascular density under physiological conditions in the healthy tis-
sue, deﬁned as the ratio of capillary wall surface to tissue volume ratio (in m-1) [34]. Also, β is a
proportionality parameter that represents the capillary growth rate (in m/s), andH(μ) = 3μ/(2μ0
+ μ) is a function that relates the production of new capillaries in the wounded region with the
concentration of chemicals promoting angiogenesis, i.e. the MDGF level, μ, (see Eq (5)).
Additionally, transport of oxygen and nutrients in the wounded-tissue space is mathemati-
cally modelled through the following reaction-diffusion PDE
_x ¼ Dx r2xþ lu u l x ; ð4Þ
where Dξ is the isotropic diffusion parameter (in m
2/s), λυ the oxygen and nutrients production
rate corresponding to the supply of the microvascular network (in m s-1), and λ the consump-
tion rate of the species by macrophages and the regenerated tissues in the wound (in s-1). How-
ever, to render oxygen balance Eq (4) independent of the corresponding reference value of the
oxygen/nutrient level, the state variable ξ is expressed above in dimensionless normalised form.
Thus, we assume that normal blood oxygen level is considered when ξ 2 [0.95, 1].
Macrophages, in addition to increasing inflammation and stimulating the immune system,
also play an important anti-inflammatory role and encourage tissue repair. The latter, namely
Oncoplastic Breast Surgery FE Modelling—Surgical Planning & Cosmetic Outcome Prediction
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M2macrophages, release growth chemicals usually referred to collectively as MDGF. MDGF in
turn stimulates the proliferation of fibroblasts, smooth muscle cells and endothelial cells, as
well as stimulating vessel growth and collagen remodelling [35, 36]. Following [33], MDGF-
species conservation is modelled as
_m ¼ Dmr2mþ x QðxÞ   m ; ð5Þ
where Dμ is the diffusion coefﬁcient (in m
2/s), while ϕ is the MDGF decay rate and ϕξ the
MDGF concentration rate under hypoxic conditions (given in s-1 and g cm-3s-1 respectively).
The source function Q describes the dependence of the MDGF level with respect to the oxygen
level in the wounded tissue site, and has the form:
QðxÞ ¼
(
1 x=x^ ; if wound and x < x^
0; elsewhere
;
where x^ represents the oxygen-level threshold below which macrophages release MDGF.
In order to effectively couple the balance equation that models cell transport with those that
describe angiogenesis, we have modified the source term on the right-hand side of Eq (1)
accordingly
_Z ¼ DZr2Zþ KðxÞ SðBÞ ð2 Z0 Z Z2Þ  k Z ; ð6Þ
where the production rate increases linearly when the oxygen and nutrient concentration is
below a prescribed threshold ~x and then is restored via the normal production value k:
KðxÞ ¼
(
kB
x=~x ; if x < ~x
kB ; elsewhere
:
However, the above set of coupled equations can be represented in a more general matrix
form
_q ¼ D  r2qþ SðqÞ ; ð7Þ
where q = {η, B, υ, ξ, μ }T,D is a diagonal matrix whose components are the corresponding dif-
fusion coefﬁcients, and vector S contains the non-linear source or sink terms arising from Eqs
(2)–(6).
The associated boundary and initial conditions to this boundary-value problem are as fol-
lows. The initial density of the cells and the microvasculature in the damaged tissue region is
set to zero. Conversely, to obtain a stable mathematical physiological wound healing and angio-
genesis model, it is assumed that cell density η = η0, oxygen level ξ = 1 and capillary density υ =
υ0 in the healthy breast tissue region and the operated/healthy–interface boundary. The two
biochemical growth-factor state variables, i.e. B and μ, are initially set to zero everywhere. Addi-
tionally, the operated (damaged) tissue domain is assumed to be contained within the healthy
(non-operated) one. Thus, the bounding surface of the computational domain of the analysed
breast geometry is distant from the surface of the interface between damaged and healthy tis-
sue. As a result, no boundary effects are expected to occur on the numerical results and, conse-
quently, it is reasonable to prescribe zero-flux boundary conditions in the computational
domain for the above biological and biochemical species.
The coupled reaction-diffusion Eq (7) is discretised using the finite element method, while
time-integration is accomplished using an explicit numerical scheme. A brief description of the
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numerical solution procedure and the adopted parameter values are provided in S2 File and S1
Table respectively.
Soft Tissue Biomechanics FE Model
Using quantities related to a reference configuration of the breast geometry, equilibrium of the
soft biological tissues subjected to finite deformations can be described by the well-known
Navier-Cauchy PDE [37]. The linear momentum equation in a Lagrangian frame of reference
reads
r  ½F  S þ r0;tissue b ¼ 0 ; ð8Þ
where F is the deformation gradient tensor and S is the symmetric 2nd Piola-Kirchhoff stress
tensor; while ρ0,tissue is the mass density of the breast tissue, and b the body force vector per
unit of mass (e.g. speciﬁc gravitational force). However, as evident from Eq (8), inertia effects
are ignored since in the present study the rate and magnitude of external loadings is very low.
In the present mechano-biological model, the stress distribution is calculated as the super-
position of the corresponding passive stresses in the tissues owing to mechanical deformations
and the active stresses effectively appearing in the wound during tissue recovery [17]: S = Spas-
sive + Sactive. Assuming breast tissues (fibroglandular and adipose tissue) can be modelled bio-
mechanically as an isotropic, quasi-incompressible, hyperelastic solid, then passive stresses can
be computed through the constitutive relation: Spassive ¼ @ W tissue=@E ; where E is the Green-
Lagrange strain tensor and W tissue an objective scalar function (0) usually referred to as
stored-energy function [37, 38]. In this work, biomechanical behaviour of breast tissues is
described through a simpliﬁed Mooney-Rivlin constitutive law
W tissue ¼ c1 ðI 1  3Þ þ c2 ðI 2  3Þ þ k 2 ðJ  1Þ2 ; ð9Þ

where J is the determinant of the deformation gradient tensor, and I 1, I 2 is the ﬁrst and second
invariant respectively of the deviatoric right Cauchy-Green tensor [38]. The parameter κ (in
Pa) represents a penalty constant to enforce incompressibility of the tissues, which is equal to
the bulk modulus in the small deformation regime. The values of the material parameters, in
Eq (9), used in this study for both breast tissue types are given in S2 Table. In the current bio-
mechanical breast model, the presence of skin tissue is also considered. The dermis and epider-
mis is approximated by an incompressible, non-linear, hyperelastic constitutive law that
accounts for large deformations. An exponential function of the stored-energy potential, origi-
nally proposed by Veronda and Westmann, is adopted (see Eq 14 in [39]; g = 0)
W skin ¼ askin ½ebskin ð~I 13Þ  1 þ c2;skin ð~I 2  3Þ ; ð10Þ
The values of the material parameters αskin, βskin and c2,skin are provided in S2 Table, while a
uniform 1.5 millimetre thickness of the skin is considered in this study.
It is widely known that fibroblasts play a major role in wound contraction (see [11, 40] and
references therein), which are cells being chemotactically attracted to the wounded tissue. In
this regard, fibroblasts generate traction forces as they advance through the ECM from the
healthy to the damaged tissue region. As a simplified approach, cell traction is mathematically
modelled as an isotropic stress tensor, with the 2nd Piola-Kirchhoff active stress distribution
expressed by: Sactive = τf ηf I, where I is the identity matrix, τf the specific traction force exerted
by the fibroblasts onto the collagen fibres in the ECM, and ηf is the fibroblast cell density in the
wounded region. This model assumes ηf to be proportional to the cell density parameter: ηf =
(αf η/η0)η0,f, where η0,f is the fibroblast cell density in the undamaged tissue region and αf a
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dimensionless proportionality parameter. Additionally, the present formulation assumes a
non-mechano-sensing model; hence, the above constitutive relationship is independent of the
specific deformation, as opposed to the active mechano-sensing models of Manousaki [15] and
Moreo et al. [41].
Another important aspect of this wound healing model is the mathematical description of
tissue recovery. In this regard, a damage factor is introduced, z, also referred to as the reduction
factor (see Chapter 6 in [38]). This internal scalar variable takes values within the range: z 2
[0, 1) and we call it “damage variable.” The damage variable quantifies the magnitude of isotro-
pic damage in the continuous hyperelastic solid and describes the health condition of the mate-
rial, i.e. the soft tissue. In the present numerical methodology, the damage variable is assumed
to be inversely analogous to the cell density in the operated tissue region, i.e. z = 1 − η/η0. At
the beginning of the wound healing simulation, z 1 inside the wound (since η 0) and zero
elsewhere (since η = η0). However, during the course of the analysis the damaged region recov-
ers, hence η increases and therefore the structural integrity of the extracellular space, i.e. the tis-
sue connectivity and coherence, increases in the same fashion. Thus, we scale the dilational
part of the strain-energy function in Eq (9) of the damaged tissues by the integrity factor, (1 −
z). The volumetric part of the tissue biomechanical constitutive equation is left intact in order
to effectively model the quasi-incompressible behaviour of the fibrotic tissue in the wound due
to the presence of biological fluids (e.g. blood plasma, serous fluid, blood clot). Additionally, z
is set to zero throughout the analysis for the non-operated (undamaged) soft tissues of the
breast model.
The elliptic Eq (8) is discretised using the finite element method. Moreover, the inertia con-
tribution in Eq (8) has been ignored, since the time evolution of the healing process is slow,
and rate effects are not considered in the present biomechanical model. Consequently, a quasi-
static, fully-implicit Total Lagrangian FE formulation [42] is implemented, where the presence
of material and geometric non-linearities in the elastic continuous medium are accounted for
in the analysis. Additionally, the material constraint of biological soft tissues (i.e. near-incom-
pressible behaviour) necessitates special formulation considerations in order to avoid degrada-
tion of the numerical results. To achieve this, hourglassing and volumetric locking side-effects
are effectively avoided by using a mixed u/p-finite element formulation, originally proposed by
Sussman and Bathe [43]. In this approach, hydrostatic pressure is introduced as an extra
unknown in the system and is separately interpolated from the unknown displacement field
variables. Following the previous section, the computational domain consists of two non-over-
lapping, interfacing volumes: the wounded tissue and the undamaged tissue surrounding the
wound. As it will become evident in the following section, the initial values for the displace-
ment and pressure variables are set to zero everywhere. The corresponding boundary condi-
tions of the biomechanical boundary-value problem are traction-free for the skin surface, fixed
displacements at the chest interface between the breast and the pectoralis fascia and prescribed
displacement components within the clipped planes of the analysed breast domain (see the
Results section for details).
To summarize the above, a three-dimensional, nonlinear FE methodology to solve the linear
momentum equations for soft tissue biomechanics is employed. A detailed description of the
numerical formulation and FE discretisation can be found in the references cited above.
Multiscale FE Model
The proposed multiscale, mechano-biological FE procedure has been implemented in C++ and
incorporated into our in-house numerical analysis framework FEB3 (see S3 File for details).
Fig 1 illustrates a flow-diagram of the 3D multiscale FE angiogenesis, wound healing and
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Fig 1. Flowchart of the multiscale FE solver. The red-dash line frames the mechano-biological wound healing, angiogenesis
and wound contraction numerical methodology (whereWH/C is wound healing/contraction).
doi:10.1371/journal.pone.0159766.g001
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contraction numerical procedure (red dashed frame). The multiscale simulation starts by con-
sidering some reference configuration (with an initial stress distribution field) of the analysed
breast geometry and a user-defined surgical plan that identifies the undamaged and the dam-
aged breast tissue regions (see subsection: Surgical Simulator for further details). The reader
should note that the associated boundary and initial conditions of both (i.e. the wound healing
and the biomechanical) FE models are as described in the above subsections.
The developed FE solver involves the numerical solution of the coupled non-linear reac-
tion-diffusion equations (wound healing and angiogenesis FE solver) and the linear momen-
tum equations (tissue solid mechanics FE solver) in a partitioned approach. The nature of
multiscaling in this formulation is due to the different time scales at which the biochemical and
the biomechanical analysis occurs. More specifically, time-integration of the transport equa-
tions for the wound healing angiogenesis simulation is accomplished through an explicit
scheme, where the order of the time increment is in the order of seconds. In contrast, the
pseudo-time increment for the biomechanics solver is of the order of several hours. In all surgi-
cal simulations in the present study, the adopted time steps for the two FE solvers are specified
as 17.28 seconds and 6 days, respectively. Evidently, the time-increment for the reaction-diffu-
sion solver is set very small in order to satisfy the Courant-Friedrichs-Lewy condition due to
the stability limitation of the adopted time-integration scheme. Nonetheless, the biomechanical
solver assumes that breast tissues deform quasi-statically hence the coarse time resolution.
Also, in the proposed numerical procedure, the state variable, η, which describes the cell den-
sity in the wounded region is shared between the two FE solvers, as shown in Fig 1. Thus, this
quantity effectively couples the biochemical and biomechanical parts of the model.
Moreover, since all governing equations are expressed in a fixed frame of reference, i.e. the
Lagrangian frame, the analysed domain remains unchanged throughout the transient analysis,
hence no FE-mesh updates and no mapping of the state variables is required.
To simulate the full tissue recovery process, the two analysis parts are alternated several
times up to the desired period of simulation time. In this work, a three month period of healing
is considered, where under physiological conditions the proliferative phase has been naturally
completed and scar maturation takes place through the last stage of remodelling and scar for-
mation. However, the proposed numerical formulation can be readily extended to an active
mechano-sensitive wound contraction and angiogenesis mathematical model, similar to the
models proposed by Olsen at al. [13] and Javierre and colleagues [17, 21]. In the present work,
we considered a simplified mechano-biological model of wound healing and angiogenesis that
requires an adequate—but not excessive—number of material parameters to describe the
mechano-chemical model. Additionally, the software architecture of the present FE solver pro-
vides the option to modify the present healing and angiogenesis model from physiological to
pathogenic conditions. This can allow us to further enhance this numerical framework and
include radiotherapy or chronic disease informed biomechanical models for soft tissues.
The two core modules of the three-dimensional FE code, namely the reaction-diffusion
explicit solver and the non-linear implicit solid solver, have been tested and verified separately
by simulating simple benchmark tests—e.g. healing of epidermal wounds as in Valero et al.
[21], or large deformation simulations of breast tissues as in Han et al. [26]—and the accuracy
of the results has been successfully compared with the commercial software ABAQUS.
Surgical Simulator
We have developed an integrated software platform—referred to as the surgical simulator—the
core of which is the mechano-biological finite element analysis solver. The simulator includes
the essential numerical algorithms that link the solver with the various input and output stages
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of the work-flow, such as the pre-processing of patient-specific imaging data, and providing
the final output: the oncoplastic breast surgery simulation.
Fig 2 illustrates the work-flow of the proposed computational procedure of the three-dimen-
sional multiscale FE surgical simulator. The process begins with step A, where MRI or com-
puted-tomography (CT) scans are acquired. If only three-dimensional surface scans are
available (i.e. no MRI or CT), then—for the reasons explained below—this and the following
step is skipped.
In step B, the patient-specific imaging data are segmented. In this procedure the breast is
delineated from the background and internal structures (i.e. adipose and fibroglandular tissues)
are differentiated. Subsequently, two- and three-dimensional patient-specific meshes are gener-
ated in step C, while in step D, the model is prepared for input into the FE solver. In this regard,
we employed the open-source software Gmsh (http://geuz.org/gmsh/) to generate high quality
three-dimensional finite element meshes. More details about pre-processing steps B to D can
be found in the published works by the authors [44, 45].
Step E involves the computation of the unloaded (i.e. gravity-free) configuration of the
patient-specific breast geometry. Typically, breast MRI acquisition takes place with the patient
prone, in which the breast is pendulous and extended anteriorly due to gravity. As a result, the
image derived patient-specific breast geometry, and hence the state of the biomechanical
model, is initially situated in a loaded condition (or under mechanical stress). We therefore car-
ried out an inverse problem analysis to retrieve the unloaded (or gravity-free) state of the breast
tissues [46]. Once the inverse simulation is finished, the FE mesh is updated by incrementing
the nodal coordinates with the newly computed displacement vector field, thus, transforming
the discretised breast geometry into the reference (or undeformed) setting.
Having virtually removed the gravitational load in the FE model, the corresponding supine
or upright shape of the breast geometry can be predicted in steps F and J respectively. This is
performed through conventional forward FE analysis simulations, as described in the Soft Tis-
sue Biomechanics FE Model subsection. In these analyses the breast tissue deformation is
assumed to be solely due to gravity, hence giving a prediction of the pre-operative patient-spe-
cific breast shape in the supine or upright configurations. The corresponding supine simulation
is, in step F, used to represent the configuration of the breast in the virtual operating room.
In step G, virtual surgery takes place in which the surgeon identifies the tumour position in
the digital breast cancer patient, and then makes a decision about which surgical plan to adopt.
In this regard, the surgeon identifies the incision lines, the outline of the excised tissues, etc. on
the discretised, three-dimensionally rendered breast model in the operating setting (i.e. in supine
pose). Subsequently, the input data of the FEmodel are automatically updated accordingly,
where the “resected” finite elements are labelled as damaged tissue (illustrated in red in Fig 2G).
The multiscale wound healing simulation is performed in step H, as described in the Multiscale
FEModel subsection. Naturally at the end of the simulation of step H, the wound will contract,
resulting in an estimate of the new breast shape several weeks after BCT treatment.
Finally, in step I, the direction of gravity is re-applied in order to predict the follow-up
breast shape in the upright position. Last but not least, the computed pre-operative upright
breast geometry, step J, and the corresponding post-operative prediction, step I, can be subse-
quently used by the surgeon (and the multi-disciplinary team) to assess the virtual OBS tech-
nique and, if necessary, investigate alternative surgical strategies.
Results
In this section, BCT intervention simulations are presented. The numerical investigation study
involves patient-specific MRI data of four breast cancer patients. These patients were recruited
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Fig 2. Pipeline of the computational procedure of the surgical simulator. The prone MRI (A) is segmented into tissue types (B) and a labelled volumetric
mesh is created, which forms the basis of the biomechanical model (C). From the prone configuration of the model (D), the unloaded state is computed (E),
from which re-application of gravity simulates the supine (F) and upright (J) configurations prior to surgery. Surgical planning, to specify the resected surgical
“wound” (shown in red), is performed in the supine pose (G) and results in a cosmetic outcome prediction (H) which is transformed into the upright
configuration (I) for presentation to the user. The pre- (J) and post- (I) surgical simulations can then be compared (dashed arrows) to reveal the predicted
deformation of the breast due to surgery. The blue arrows indicate the direction of gravity: (D) from posterior to anterior (i.e. prone), (F,G,H) from anterior to
posterior (i.e. supine) and (I,J) superior to inferior (i.e. upright). Note in G and H, the breast skin is shown transparent to visualise the excision region located
inside the breast model (see also the adopted surgical plans in the Results section).
doi:10.1371/journal.pone.0159766.g002
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at the Royal Free Hospital in London, in accordance with the PICTURE Breast L protocol and
patient consent was obtained (see Ethics). All acquired clinical data were anonymised and, to
allow internal processing, the following codes P-1, P-2, P-3 and P-4 are associated with the
data-set of each patient respectively. None of these patients received adjuvant or neo-adjuvant
chemotherapy but all received post-surgical radiotherapy.
Orthogonal views of the MRIs of the four patients considered in this analysis are shown in
S2 Fig. The images are structural, non-contrast-enhanced, non-fat suppressed, T1-weighted
(P-1 and P-4), or where available T2-weighted (P-2 and P-3). The spatial resolution of the MRI
sequences is between 0.57 × 0.57 × 3 mm3 and 0.71 × 0.71 × 3 mm3. Both sequences allow
good spatial differentiation between adipose and fibroglandular tissue and do not require dif-
ferent processing during the generation of the biomechanical model. As mentioned above,
image acquisition is carried out with the patient lying in the prone position and the breast is
pendulous in a dedicated receiver coil with cushioned patient support. Therefore, due to the
effect of gravity, the breasts are naturally pulled into the anterior direction.
Careful inspection of the images and 3D models reveals an important limitation imposed by
the MRI acquisitions: the skin of the patient is frequently in contact with the scanning device.
This contact is especially apparent for patients with larger breast sizes, such as P-1, P-3 and P-4
(see S2 Fig) but it is also present for patient P-2. Hence, gravity is not the only load deforming
the breast tissues and the skin, but also surface traction forces are present due to the rigidity of
the support system and friction between the surfaces involved. Presently, it is not experimen-
tally feasible to quantitatively measure those contact forces during imaging. As a consequence,
during the FE model preparation for the surgical simulation (see step D in Fig 2) contact and
friction have been ignored. Inevitably, it is expected that the inverse simulation in step E could
potentially give an erroneous estimate of the gravity-free configuration of the analysed patient-
specific breast geometry.
The FE models (see illustrations in S3 Fig) are generated following the procedure described
in the Surgical Simulator, starting with segmentation of the MRI scans of the patients. The ana-
lysed domain of the FE models is bounded by clipping the segmented breast image in the supe-
rior and inferior aspects as well as laterally (see Fig 3). Subsequently, three-dimensional finite
element unstructured meshes of all patient-specific models are generated. The meshes
Fig 3. FEmesh and boundary conditions on the patient-specific breast model. Different views of the 3D finite element unstructured mesh of the P-1-
specific breast model in prone position. Each colour represents the boundary condition considered in the model: traction-free skin and lateral surface, Z-
component of displacement is zero prescribed on the superior and inferior horizontal (Y-plane) boundaries, and chest-wall is fixed.
doi:10.1371/journal.pone.0159766.g003
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comprise of 5,235, 4,213, 4,571 and 5,110 nodes, having 21,556, 15,485, 19,162 and 21,100 tet-
rahedral elements respectively.
In addition, boundary conditions are applied to the models in order to resemble anatomical
conditions (see Fig 3). The skin and the two lateral clipping planes are considered traction-free,
the displacements on the pectoralis major fascia interface are fixed completely (i.e. uX,Y,Z = 0),
while the axial displacement is fixed (uZ = 0) in the horizontally clipped planes. The initial con-
ditions for the boundary-value problem of the coupled mechano-biological mathematical
model are described in the Wound Healing and Angiogenesis FE Model and Soft Tissue Bio-
mechanics FE Model subsections.
Virtual surgical planning is ideally done in the same orientation as the patient in the operat-
ing room environment, which is usually the supine position. As such, Fig 4 illustrates all
patient-specific breast geometries in the simulated supine pose, where the tumour is shown as
a spheroid (left column). In the same figures, the surgeon has defined the volume of the excised
tissue including margins, has drawn the incision lines on the skin and the incision path inside
the breast (not shown here) which is not directly related with the excised tissue. In the present
study of in-silico breast surgery, we adopted a rather conventional approach of tissue resection
during OBS. Breast tissue and lesion removal is accomplished by considering a cylinder, whose
axis is perpendicular to the chest-wall surface and extends from the skin to the fascia. Tissues
enclosed by the cylinder are expected to be removed by the surgeon in real surgery, and hence
are “virtually excised” from the patient-specific model. However, we assume that no skin is
resected or severely wounded, while the operated breast tissue is encapsulated by a reasonably
smooth boundary that does not intersect with the fascia or the skin. Thus, the FE model is
updated accordingly in order to differentiate the non-operated part of the breast tissues from
the excised tissue region. In this regard, the tetrahedral elements of the FE volume mesh that lie
inside the operated region are marked as wound (as in the segmentation step; see Fig 2B) hav-
ing different biomechanical properties from the healthy counterpart (see S2 Table). Fig 4 (right
column) depicts the tetrahedral elements (in yellow) of the volume mesh that correspond to
the wounded site. Also, S3 Table summarizes some characteristics of the four patient-specific
breast models. These include the total volume of the analysed domain of the breast, the volume
of the excised tissues, and the amount of adipose and fibroglandular tissues. It becomes evident
from this table that patient-specific breast model P-1 represents a relatively fatty breast (having
a fibroglandular-to-adipose tissue ratio of approximately 1:6) as opposed to patient P-2 which
can be regarded as very dense (having a 1:3 ratio). Note that the volume ratios are calculated
over the breast region only. In contrast, the simulated domain extends further lateral and pos-
terior to clipping boundaries that were set to be reasonably far away from the breast in order to
minimize effects from the boundary conditions on the simulation. Hence the whole simulated
domain is bigger than what is normally regarded as the anatomical definition of the breast as
an organ.
Skin is also considered in the present study and is modelled using membrane elements. The
dermis with the epidermis is assumed to be uniform in all breast models, 1.5 mm. Given the
thickness and skin surface area, the total mass of the skin for each patient-specific model is esti-
mated to be 162 g, 92 g, 187 g, and 220 g respectively.
The material parameters used in the present analysis for the biochemical and biomechanical
models are provided in S1 and S2 Tables. A large number of parameters are taken from the lit-
erature, whereas some parameters (especially those for the angiogenesis biochemical model)
have been estimated after numerical trials when plausible results are obtained.
Fig 5 shows the normalised dimensionless cell density, η, and capillary density, υ, at various
time frames during the wound healing process for case P-3. Both quantities initially have zero
value in the damaged region. During the course of the simulation, the healing mechanism
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Fig 4. Adopted surgical plans in supine configuration, depicting the tumour location and the breast tissue resected. The “idealised” surgical plan
(SP) for each patient (recorded by the breast surgeon) is presented in the left column. Tumour position is shown with a red sphere and the excised breast
tissues with a green transparent cylinder. In the right column, the FE models are informed by labelling the corresponding volume elements as resected tissue
(shown in yellow).
doi:10.1371/journal.pone.0159766.g004
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induces tissue repair and the species at the end of the healing process reach balance. The termi-
nal value of the species η, υ and ξ (not shown here) in the now-recovered tissue region is equal
to η0, υ0 and 1 respectively, as in the non-operated breast tissues. We have also carried out sim-
ulations (not presented herein) where we tested both chemically-driven cell mitosis mecha-
nisms (as described in the Wound Healing and Angiogenesis FE Model subsection) i.e.
activator and inhibitor [11]. Interestingly, and in agreement with the results reported by Sher-
ratt and Murray, we observed that biochemical inhibition and activation of mitosis produced
very similar numerical results in terms of the soft tissues wound recovery rate, and the breast
skin deformations. However, the present study considered the activator mitosis mechanism in
the wound healing simulations.
The original shape of the wounded region is not preserved during healing, and contraction
is observed to be more pronounced at the low-curvature regions of the wound surface (see ani-
mation in S1 Video). These predictions are qualitatively in agreement with the wound contrac-
tion observations reported in the previously published mathematical models of epidermal
tissue scarring [13, 17]. Fig 6 illustrates the relative wound contraction of all example cases
over the course of the simulation time. The contraction to between 91 and 93% of the original
volume is, of course, largely dependent on the choice of biochemical parameters (see S1 Table).
The same holds true for the temporal course of the contraction. With the current set of param-
eters it is suggested that the breast reaches its final shape after about 30 days. Note that this
simulation assumes no further treatment after surgery, which is of course a simplification of
the post-surgical patient work-up. Regarding wound contraction, it has been observed by clini-
cians that the breast tissues at the wound site (after lumpectomy) stiffen as a result of the heal-
ing process and fibrosis occurring in the vicinity of the wound. This observation is supported
by the reported possible disfigurements caused by BCT, and the proposed breast model takes
this effect into consideration.
The simulated wound contraction results in a deformation of the breast which, due to the
connectivity of breast tissues, has an effect on the surrounding tissues. As shown in the surgical
plans above (see Fig 4), the excision volume for patient P-1 is located in the lower outer quad-
rant, for patients P-2 and P-4 in the upper outer quadrant, and for patient P-3 in the upper
inner quadrant. Thus, depending on the size and location of excised tissue, the maximum dis-
placement magnitude in the upright position ranged from 5 mm (patient P-2) to 1.6 cm
(patient P-4) approximately. The vector illustrations in Fig 7 highlight the deformation distri-
bution on the breast skin (magnitude of the displacement vector in metres). As evident from
this figure, after BCT treatment and recovery, tissue deformation is more pronounced at the
breast skin surface proximal to the wounded region, which then causes the overall breast shape
to deform.
To communicate the results between clinical staff and patients, photo-realistic visualisations
could be useful to avoid the need for the patient to interpret a non-specific biomechanical
mesh. In order to visualise the predicted outcome in a photo-realistic way therefore, we consid-
ered the following two issues. First, as reported earlier, the patient’s breast shape can be severely
deformed during MRI acquisition. This has been observed in our experiments to have a direct
Fig 5. Snapshots of the cell and capillary density predictions during wound healing simulation.
Numerical results of the wound healing simulation for patient-specific model P-3 (in supine) depicting the
evolution of cell and capillary density at various time instants. The operated breast is clipped to facilitate
visualisation of the dynamic changes of the species in the wounded area. The left and right column depict the
(normalised dimensionless) cell and capillary density, respectively.
doi:10.1371/journal.pone.0159766.g005
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effect on the FE predictions. As a result, skin surface distortion needs to be removed from the
breast model. Second, the texture needs to be properly transferred to the patient-specific bio-
mechanical model. To achieve both goals, initially, we rigidly align the optical surface scan of
the patient in the upright position with the corresponding upright prediction of the bio-
mechanical model. Subsequently, the residual discrepancy between the simulation and the sur-
face scan is removed by a surface warping technique, resulting in an accurate match of the two
meshes involved [47]. This permits not only transfer of the texture onto the skin elements of
Fig 6. Predicted volume reduction of the operated tissue region during wound recovery. Numerical results of the normalised volume reduction of the
operated (excised) tissue region during wound healing of all four patient-specific models. Note the initial slow volume contraction due to inflammation,
followed by a pronounced contraction during the proliferative stage (day-8 to day-16) and final convergence to a smooth plateau in the remodelling phase
(day-24 and onwards) of healing.
doi:10.1371/journal.pone.0159766.g006
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the biomechanical model but also projection of the deformations predicted by the wound heal-
ing/contraction simulation onto the textured skin surface. Fig 8 presents the results of our
alignment and displacement projection strategy for all cases, where we compare the textured
surface mesh before and after surgery.
The simulated post-surgical surfaces were further exploited in order to both validate the
developed mathematical models, and evaluate the prediction accuracy of the surgical simula-
tion tool. To this end, follow-up data, in the form of 3dMD surface scans, were acquired 6 to 12
months after surgery for each patient and compared directly with the predicted surgical
Fig 7. Vector representation of breast surface deformation after BCT. Arrow vector representation of the computed displacement field on the breast
surface of the patient-specific post-operative model (after wound healing) with respect to the pre-operative setting in the upright position (transparent grey
surface). The tan-coloured background surface corresponds to the chest wall boundary of the in-silico model. Note that all breast geometries are shown in
the same scale.
doi:10.1371/journal.pone.0159766.g007
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outcome. Rigid alignment between the simulated and acquired follow-up surface is established
using an iterative closest point algorithm [48]. After rigid alignment, the surface distance d
between the simulation and the follow-up acquisition is measured. The results, in terms of
mean distance and standard deviation, as well as 50th, 90th, and 95th percentile values for each
patient are given in Table 1. Fig 9 illustrates for each patient case: (i) the follow-up surface
scan, (ii) the simulated surgical outcome colour-coded with d (in mm), the measured distance
between the simulation result and the follow-up surface, and (iii) the corresponding histogram
of the distance values.
The mean surface distances between the simulation and the follow-up optical surface scan
range between 2.8 and 4.1 millimetres. This indicates an excellent simulation accuracy, espe-
cially when viewed in the light that additional aspects might have influenced the breast shape
Fig 8. Comparison of simulated breast shape (with texture) before and 3months after surgery. Baseline biomechanical model (wireframe) with fitted
upright surface scan that visualises the skin and oreola texture before surgery (left column). In view of the recorded surgical plan (cf. Fig 4), the surgical
simulation tool predicted the breast shape following BCT (right column). The breast deformations resulted from the in-silico analysis are then projected onto
the original surface scan to visualise the textured post-surgical breast shape.
doi:10.1371/journal.pone.0159766.g008
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during the one-year follow-up period. For P-2, for instance, a weight loss between the two
image acquisition time points was observed which increased the distance measured between
surfaces laterally. The deformity observed for case P-1 was also well predicted by the simulation
in terms of surface displacement. However, the actual deformity was more pronounced than
the simulation predicted, more precisely, the change of the orientation of the left nipple from
anterior to inferior was not accurately predicted by the simulation. For case P-3 the simulation
predicted a slightly larger influence of surgery in the upper inner quadrant of the left breast
than actually occurred. However the overall shape and appearance between simulation and fol-
low-up was very similar. All together, the evaluation with follow-up surface scans suggests that
the implemented mechano-biological simulation framework is well capable of predicting surgi-
cal outcome with clinically useful accuracy. Slight over- and under-prediction of the actual
deformity is to be expected due to inter-patient variability.
In summary, we strongly believe that such photo-realistic illustrations can provide impor-
tant information to the surgeon and their patient, as well as informing both of the expected
deformities occurring at the skin and to the internal structure of the patient’s breast. The pro-
posed computational framework therefore demonstrates significant potential to aid surgical
decision making and, hence, improve the accuracy of cosmetic predictions of OBS treatment.
Discussion
An integrated and validated computational framework for the numerical prediction of onco-
plastic breast conserving interventions for early breast-cancer treatment has been presented.
The proposed three-dimensional multiscale finite element model is capable of simulating
wound healing, angiogenesis and wound contraction of breast tissues. To the authors’ knowl-
edge, this is the first complete three-dimensional, full-scale attempt to realistically model the
biomechanics of female breast tissues and the biological processes associated with wound heal-
ing and angiogenesis after BCT.
The simulations, derived from routine clinical prone MR scans of four subjects, selected
chronologically from a longitudinal cohort of breast conserving surgery patients, have been val-
idated using 3D surface scans acquired six to twelve months after surgery, via a high accuracy
3dMD commercial imaging system. The measured mean surface distances of between 2.8 and
4.1 mm encapsulate errors due to the surgical simulation, as well as other factors including the
gross prone to unloaded to upright simulation, population based material parameter selection
and external factors such as weight gain or loss.
The present work demonstrates the potential of the oncoplastic breast surgery simulator we
have developed to predict the cosmetic outcome of breast conserving therapy. The proposed
computational platform could prove a valuable tool for surgical decision support and for
Table 1. Validation results of the in-silico model and the surface optical scans.
Patient mean std. 50th perc. 90th perc. 95th perc.
P-1 3.1 3.1 2.3 6.2 8.2
P-2 3.2 2.4 2.6 6.7 7.6
P-3 2.8 2.7 2.0 5.7 7.7
P-4 4.1 3.3 3.5 8.7 10.6
Measurements of the surface distance, d, (in mm) between the surgical simulation predictions and the rigidly aligned follow-up optical surface scans. The
last three columns give the 50th, 90th, and 95th percentile values respectively for each patient.
doi:10.1371/journal.pone.0159766.t001
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Fig 9. Comparison between the acquired follow-up surface scans and the in-silico predictions. The follow-up surface scan (6–12 months after
surgery) with the patients in standing position is illustrated on the left-hand side column of the figure. In the centre column, the breast shape 3 months after
BCT—predicted by the surgical simulation tool—is shown. The colour map represents the measured distance, d, between the rigidly aligned follow-up scan
and the simulated surgical outcome. On the right-hand side column, the histogram to the normalised frequency of occurrence, n, against distance, d, is
presented.
doi:10.1371/journal.pone.0159766.g009
Oncoplastic Breast Surgery FE Modelling—Surgical Planning & Cosmetic Outcome Prediction
PLOS ONE | DOI:10.1371/journal.pone.0159766 July 28, 2016 22 / 27
multi-disciplinary team meetings, as well as a useful tool to support patient–surgeon interac-
tion in a shared decision making process, to aid reliable aesthetic outcome prediction and
assessment.
The present model does not account for the side-effects of adjuvant therapies, e.g. radiother-
apy or chemotherapy. Indeed, as Vrieling et al. [49] reported, the final cosmetic outcome of
breast conserving interventions is not only dependent on the breast shape, breast size and
tumour volume but also on the radiotherapy treatment process itself. As a consequence, it is
essential to enhance the current mathematical model to account for the effects of such adjuvant
treatment procedures. An outstanding issue is the breast tissue deformation that occurs during
the MRI acquisition due, for instance, to skin contact with the scanning device. This can lead
to an inaccurate estimation of the gravity-free breast geometry, which will in turn impact the
corresponding prediction of the breast shape in the upright pose. For this reason, we are
actively investigating methods by which the input MR data could be corrected for any non-
gravitational forces present during the image acquisition.
In future work we will also extend the present physiological tissue recovery model to
account for pathological healing, by incorporating the effect of radiotherapy treatment into the
biomechanics and biochemics modules. We will model the impact of radiotherapy in wound
recovery and specifically how radiation alters tissue stiffness and the natural healing mecha-
nism, e.g. changes in the capillary network growth and formation, proliferation of fibroblasts,
and varying levels of regulatory growth factors [50]. We will investigate the effects of soft tissue
stiffening and fibrosis on the overall breast shape, using non-invasive imaging modalities that
can measure elastic properties of tissues, e.g. magnetic resonance elastography [51].
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S1 File. The Biology of Wound Healing and Angiogenesis.
(PDF)
S2 File. Finite Element Discretisation of the 1st-order PDEs.
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S3 File. Implementation of the Multiscale Mechano-biological FE Framework.
(PDF)
S1 Fig. Phases of Physiological Wound Healing. Time-history (in days) schematic illustration
of the various phases of tissue regeneration and recovery under physiological conditions [7].
(TIF)
S2 Fig. MRI Scans of the Breast Cancer Patients. Orthogonal views of magnetic resonance
images with the patients lying in prone position.
(TIF)
S3 Fig. Patient-specific FE Models. Caudal and lateral views of the three-dimensional finite
element meshes of the patient-specific models derived from processing the MRI scans. The tet-
rahedral elements in the models correspond to fibroglandular tissue while adipose elements are
not shown for visualisation purposes.
(TIF)
S1 Table. Wound Healing and Angiogenesis Model Parameters. List of all the parameters
used in the biochemical finite element breast model, and references to the published papers are
also provided.
(PDF)
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S2 Table. Soft Tissue Biomechanics Model Parameters. List of all the parameters used in the
biomechanical finite element breast model, and references to the published papers are also pro-
vided.
(PDF)
S3 Table. Feature Characteristics Related to Tissue Volume of the Patient-specific Breasts.
The model corresponds to the total volume, in cm3, of the analysed geometry. In the third col-
umn, an estimate of the left (L) and right (R) breast volume is provided, while the fourth and
fifth columns indicate the composition of adipose and fibroglandular tissue in each breast
respectively. Asterisks denote the operated breast (L or R) where tissues have been “virtually”
removed.
(PDF)
S1 Video. Wound Healing Simulation for Patient Case P-4: Displacement Field. The solid
arrows in the animation represent the displacement field that correspond to the breast tissue
deformation analysis (from the unloaded to the supine configuration) due to the effect of grav-
ity and the contraction of the wound during the healing process. The colour-map illustrates the
magnitude of the displacement vector (in cm). Note also the dynamic change of the initially
excised volume of breast tissue which contracts during healing. The two-dimensional plot at
the bottom of the animation depicts the dynamic change of the volume of the operated tissue,
where the horizontal axis corresponds to days.
(AVI)
S2 Video. Wound Healing Simulation for Patient Case P-4: Capillary Density. The volume
rendering represents the (normalised dimensionless) capillary density, υ/υ0, in the operated tis-
sue region. At the beginning of the simulation no capillaries are present in this region, hence υ/
υ0 = 0. During the wound healing simulation new sprouts are forming at the undamaged–oper-
ated breast tissue interface, therefore, neo-vascularisation extends (modelled here as a diffusion
process) towards the centre of the operated region. At the end of the analysis, after 50 days
approximately, the capillary density has been restored locally thus reaching its maximum
value, and vascular growth comes nearly to a halt. For explanation of the two-dimensional plot,
see the description in S1 Video.
(AVI)
S3 Video. Wound Healing Simulation for Patient Case P-4: Cell Density. The volume ren-
dering represents the (normalised dimensionless) cell density, η/η0, in the wounded region. At
the early stages of the simulation—similarly to S2 Video—cells (i.e. fibroblasts) are migrating
and proliferating towards the wound, while mitosis of cells (e.g. myofibroblasts, etc.) is also
supported by the newly formed vascular network in this region. Evidently, one month after
BCT, an established extracellular matrix is formed, tissue granulation nearly completes and the
breast tissue start to remodel and mature, hence, the decreasing rate of deformation at the
operated breast. For explanation of the two-dimensional plot, see the description in S1 Video.
(AVI)
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